Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy

enthalten in: BJR open | 2019

von Carlin, D. | Weller, A. | Kramer, G. | +9